VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -- | 672.41% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -- | 672.41% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -100.00% | 1,046.00% | 672.41% | -- |
| SG&A Expenses | -21.11% | -22.03% | 25.94% | 16.28% | -12.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.52% | -20.32% | 4.28% | 22.84% | -14.74% |
| Operating Income | 32.23% | 17.66% | 1.06% | -20.60% | 14.50% |
| Income Before Tax | 24.19% | 10.19% | -4.77% | -24.95% | 11.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.19% | 16.75% | -4.77% | -24.95% | 11.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.19% | 16.75% | -4.77% | -24.95% | 11.31% |
| EBIT | 32.23% | 17.66% | 1.06% | -20.60% | 14.50% |
| EBITDA | 32.21% | 17.58% | 0.97% | -20.70% | 14.47% |
| EPS Basic | 26.79% | 18.97% | -3.57% | -24.53% | 11.11% |
| Normalized Basic EPS | 25.71% | 11.11% | -2.86% | -24.24% | 12.50% |
| EPS Diluted | 26.79% | 18.97% | -3.57% | -24.53% | 11.11% |
| Normalized Diluted EPS | 25.71% | 11.11% | -2.86% | -24.24% | 12.50% |
| Average Basic Shares Outstanding | 3.46% | 2.86% | 0.42% | 0.23% | 0.20% |
| Average Diluted Shares Outstanding | 3.46% | 2.86% | 0.42% | 0.23% | 0.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |